Частота сердечных сокращений как фактор риска развития сердечно-сосудистых заболеваний
https://doi.org/10.18705/1607-419X-2008-14-4-324-331
Аннотация
Об авторах
А. А. СвистуновРоссия
Т. В. Головачева
Россия
К. Ю. Скворцов
Россия
О. С. Вервикишко
Россия
Список литературы
1. Федеральная служба государственной статистики. Россия в цифрах. М:2006.
2.
3. Оганов Р.Г., Глезер М.Г., Деев А.Д. и др. Российское исследование ПАРАЛЛЕЛЬ. Программа по выявлению пациентов с неэффективной терапией beta-адреноблокаторами и сравнительной оценке добавления к терапии триметазидина МВ или изосорбида динитрата при стабильной стенокардии. Кардиология 2007;3:4−13.
4.
5. Шальнова С.А., Деев А.Д., Оганов Р.Г. и др. Частота пульса и смертность от сердечно-сосудистых заболеваний у российских мужчин и женщин. Результаты эпидемиологического исследования. Кардиология 2005;10: 45−50.
6.
7. Карпов Ю.А., Деев А.Д. Программа АЛЬТЕРНАТИВА - исследование АнтиангинаЛЬной эффекТивности и пЕРеносимости кораксаНА (ивабрадина) и оценка качесТва жИзни пациентоВ со стАбильной стенокардией: результаты эпидемиологического этапа. Кардиология 2008;5:30−35.
8.
9. Palatini P., Julius S. Heart rate and cardivascular risk. J Hypertens 1997;15: 3−17.
10.
11. Palatini P., Benetos A., Grassi G. et al. Identification and management of the hypertensive patient with elevated heart rate: statement of European Society of Hypertension Consensus Meeting. J Hypertens 2006;24:603−610.
12.
13. Levy R.L., White P.D., Stroud W.D. et al. Transient tachycardia: prognostic significance alone and with association with transient hypertension. JAMA 1945;129:585−588.
14.
15. Dyer A.R., Persky V., Stamler J. et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980;112:736−749.
16.
17. Kannel W.B., Kannel C., Paffenbarger Jr. R.S. et al. Heart rate and cardiovascular mortality: the Framingham study. Am Heart J 1987;113:1489−1494.
18.
19. Gillum R.F., Makuc D.M., Feldman J.J. Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J 1991;121:172−177.
20.
21. Menotti A., Mulder I., Nissinen A. et al. Cardiovascular risk factors and 10-year all-cause mortality in elderly European male populations: the FINE study (Finland, Italy, Netherlands, Elderly). Eur Heart J 2001;22:573−579.
22.
23. Gillmann M.W., Kannel W.B., Belanger A. et al. Influence of heart rate on mortality among persons with hypertension: the Framingham study. Am Heart J 1993;125:1148−1154.
24.
25. Benetos A., Rudnichi A., Thomas F. et al. Influence of heart rate on mortality in a French population: role of age, gender and blood pressure. Hypertension 1999;33: 44−52.
26.
27. Palatini P., Thijs L., Staessen J.A. et al. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002;162:2313−2321.
28.
29. Perk G., Stessman J., Ginsberg G. et al. Sex differences in the effect of heart rate on mortality in the elderly. J Am Geriatr Soc 2003;51:1260−1264.
30.
31. Filipovsky J., Ducimetiere P., Safar M.E. Prognostic significance of exercise blood pressure and heart rate in middle-aged men. Hypertension 1992; 20:333−339.
32.
33. Reunanen A., Karjalainen J., Ristola P. et al. Heart rate and mortality. J Intern Med 2000;247:231−239.
34.
35. Savonen K.P., Lakka T.A., Laukkanen J.A. et al. Heart rate response during exercise test and cardiovascular mortality in middle-aged men. Eur Heart J 2006; 27:582−588.
36.
37. Jouven X., Empana J.P., Schwartz P.J. et al. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 2005;352:1951−1958.
38.
39. Palatini P., Casiglia E., Julius S.et al. High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med 1999;159:585−592.
40.
41. Disegni E., Goldbourt U., Reicher-Reiss H. et al. The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group (Secondary Prevention Reinfarction Israeli Nifedipine Trial). J Clin Epidemiol 1995;48: 1197−1205.
42.
43. Berton G.S., Cordiano R., Palmieri R. et al. Heart rate during myocardial infarction: relationship with one-year global mortality in men and women. Can J Cardiol 2002;18: 495−502.
44.
45. Palatini P. Heart rate as a cardiovascular risk factor: do women differ from men? Ann Med 2001; 33:213−221.
46.
47. Palatini P., Winnicki M., Santonastaso M. et al. Reproducibility of heart rate measured in the clinic and with 24-hour intermittent recorders. Am J Hypertens 2000;13:92−98.
48.
49. Aronow W.S., Ahn C., Mercando A.D. et al. Association of average heart rate on 24-hour ambulatory electrocardiograms with incidence of new coronary events at 48-months follow-up in 1,311 patients (mean age 81 years) with heart disease and sinus rhythm. Am J Cardiol 1996;78:1175−1176.
50.
51. Sega R., Facchetti R., Bombelli M. et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005;111:1777−1783.
52.
53. Hozawa A., Ohkubo T., Kikuya M. et al. Prognostic value of home heart rate for cardiovascular mortality in the general population: the Ohasama study. Am J Hypertens 2004;17:1005−1010.
54.
55. Hjalmarson A., Gilpin E.A., Kjekshus J. et al. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol 1990;65:547−553.
56.
57. Copie X., Hnatkova K., Staunton A. et al. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction: results of two-year follow-up study. J Am Coll Cardiol 1996;27:270−276.
58.
59. Abildstrom S.Z., Jensen B.T., Agner E. et al. Heart rate versus heart rate variability in risk prediction after myocardial infarction. J Cardiovasc Electrophysiol 2003;14:168−173.
60.
61. Lee K.L., Woodlief L.H., Topol E.J. et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trail of 41,021 patients. GUSTO-I Investigators. Circulation 1995; 91:1659−1668.
62.
63. Marchioli R., Avanzini F., Barzi F. et al. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J 2001;22:2085−2103.
64.
65. Diaz A., Bourassa M.G., Guertin M.C. et al. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005;26:967−974.
66.
67. Bassiouny H.S., Zarins C.K., Kadowaki M.H. et al. Hemodynamic stress and experimental aortoiliac atherosclerosis. J Vasc Surg 1994;19:426−434.
68.
69. Beere P.A., Glagow S., Zarins C.K. Retarding effect of lowered heart rate on coronary atherosclerosis. Science 1984; 226:180−182.
70.
71. Kaplan J.R., Manuck S.B., Adams M.R. et al. Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet. Circulation 1987;76:1364−1372.
72.
73. Albaladejo P., Carusi A., Apartian A. et al. Effect of chronic heart rate reduction with ivabradine on carotid and aortic structure and function in normotensive and hypertensive rats. J Vasc Res 2003;40:320−328.
74.
75. Perski A., Olsson G., Landou C. et al. Minimum heart rate and coronary atherosclerosis: independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age. Am Heart J 1992;123:609−616.
76.
77. Huikuri H.V., Jokinen V., Syvanne M. et al. Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1999;19:1979−1985.
78.
79. Palatini P. Exercise haemodynamics in the normotensive and the hypertensive subject. Clin Sci 1994;87:275−287.
80.
81. Mangoni A.A., Mircoli L., Giannattasio C. et al. Heart rate-dependence of arterial distensibility in vivo. J Hypertens 1996;14:897−901.
82.
83. Mangoni A.A., Mircoli L., Giannattasio C. et al. Effect of sympathectomy on mechanical properties of common carotid and femoral arteries. Hypertension 1997;30:1085−1088.
84.
85. Heidland U.E., Strauer B.E. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 2001;104:1477−1482.
86.
87. Graham I., Atar D., Borch-Johnsen K. et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2007;28:2375−2414.
Рецензия
Для цитирования:
Свистунов А.А., Головачева Т.В., Скворцов К.Ю., Вервикишко О.С. Частота сердечных сокращений как фактор риска развития сердечно-сосудистых заболеваний. Артериальная гипертензия. 2008;14(4):324-331. https://doi.org/10.18705/1607-419X-2008-14-4-324-331
For citation:
Svistunov A.A., Golovacheva T.V., Skvortsov K.Yu., Vervikishko O.S. Heart Rate As A Risk Factor for Development of Cardiovascular DiseasesA Review. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2008;14(4):324-331. (In Russ.) https://doi.org/10.18705/1607-419X-2008-14-4-324-331